IRTC Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -5.86%, SMA50 -13.7%, SMA200 -13.67%). The stock’s 14-day RSI is 39.55 (weak momentum), while the ATR of 8.16 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -33.88% below its high and over 51.51% above its low. Average 10-day trading volume of 386.27 thousand shares is below the 3-month average of 605.90 thousand, indicating normal recent market interest.

iRhythm Technologies, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $192.30. This means the shares are trading below this model’s fair value.

iRhythm Technologies, Inc. has 32.13 million shares outstanding. The public float is 31.75 million shares, elevated short interest at 8.78% of float. This equals 2.52 million shares. The short ratio is 5.8 days. Institutional investors hold 113.52% of the float. Insiders own 0.94%. King Kevin M holds 250.42 thousand shares, Blackford Quentin S. has 204.16 thousand shares and Murphy Patrick Michael has 63.20 thousand shares. Over the past six months, insider transactions show net selling. They sold 114.58 thousand shares across 25 transactions.

iRhythm Technologies, Inc. (NASDAQ:IRTC) closed at $120.88 USD, losing -$3.53 (-2.84%) from the previous close of $124.41. The stock is currently mid-range between its 52-week high and low $97.16 and $212.00. With a market capitalization of about $3.91 billion, iRhythm Technologies, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.18). Key stats such as the average daily volume over the past year has been around 621.84 thousand shares, volume is running light vs its 52-week average. Headquartered in San Francisco, CA, iRhythm Technologies, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Quentin S. Blackford, the company employs approximately 2,000 people and listed since October 20, 2016. iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States.

iRhythm Technologies, Inc. generated EPS of -$1.41 over the past year. Five-year average earnings growth is 2.49%. The latest quarter delivered EPS of -$0.16. The next quarter is forecast at -$0.62. Next year's EPS is expected at $30.66. Analyst sentiment is bullish. Analyst rating data shows there are 13 Strong Buy ratings, 20 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $244.00 to $147.00. The high target offers 98.0% upside. The low target suggests 19.29% downside. The mean target is $201.00. This offers 63.11% upside. iRhythm Technologies, Inc. earnings surprise history is a mixed track record. The quarter that ended October 30, 2025, missed forecasts by -55.56%. The prior quarter beat by -39.62%. Over the last six quarters, Apple has recorded several small beats. These include -29.83% in August 01, 2024.

iRhythm Technologies, Inc. trades at a P/E ratio of -88.62, slightly below the S&P 500 average, with a price-to-sales ratio of 5.29 and a price-to-book ratio of 25.85 reflecting a rich premium to book value. The P/FCF stands at 114.58, also above market averages. Compared to sector medians, iRhythm Technologies, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Our AI price prediction model suggests that iRhythm Technologies, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -0.45%, with price expected at $122.67 by April 28, 2026, within a range of $118.63 to $126.95 3-Month Outlook: Projected rise of 23.33%, reaching $151.98 by July 13, 2026, with a range of $149.65 to $154.01. 1-Year Outlook: Projected gain of 17.15%, with price at $144.36 by April 14, 2027, within a range of $135.68 to $155.31.

iRhythm Technologies, Inc. (NASDAQ:IRTC) shares are flat -6.67% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows iRhythm Technologies, Inc. trading at a premium to the broader market with a P/E of -88.62. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $160.49, suggesting 30.24% upside. Our AI forecast model points to short-term weakness (-0.45% over two weeks), a medium-term rise (23.33% over three months), and a longer-term gain (17.15% over one year), with expected trading ranges indicating moderate volatility.